Aduro Biotech
ADRO
#8321
Rank
ยฃ0.17 B
Marketcap
ยฃ10.78
Share price
4.18%
Change (1 day)
N/A
Change (1 year)

Revenue for Aduro Biotech (ADRO)

Revenue in 2020 (TTM): ยฃ22.41 Million

According to Aduro Biotech's latest financial reports the company's current revenue is ยฃ20.63 Million. In 2019 the company made a revenue of ยฃ12.74 Million an increase over the revenue in the year 2018 that were of ยฃ11.13 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aduro Biotech from 2014 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)ยฃ22.41 M75.95%
2019ยฃ12.74 M14.39%
2018ยฃ11.13 M-12.48%
2017ยฃ12.72 M-65.99%
2016ยฃ37.41 M-30.55%
2015ยฃ53.87 M445.07%
2014ยฃ9.88 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sarepta Therapeutics
SRPT
ยฃ1.78 B 8,533.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ0.52 B 2,432.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
ยฃ61.69 M 198.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
ยฃ0.71 M-96.56%๐Ÿ‡ฉ๐Ÿ‡ช Germany